Sttr phase II
Ended Definitive Contract Awarded Last action
- Contract number
- W911QY20C0114
- Awardee
-
Pathovacs Inc. UEI GAEYBFGAB1N9
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Obligated
- $975,606
Award facts
- Contract value 100% obligated
- $975,605.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 11 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Ames, IA 50011, USA
- Research
- STTR Phase II
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $469,366 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $506,239 |
About this award
The U.S. Army awarded a $975,605.67 firm fixed price STTR Phase II contract to Pathovacs Inc., a small, minority-owned biotechnology company based in Ames, Iowa. The contract, set aside for small businesses, supports Pathovacs' research and development of chemical and biological defense technologies for the Joint PEO Chemical and Biological Defense program. Pathovacs specializes in developing novel vaccines and diagnostic technologies for infectious diseases in both humans and animals. This award builds on the company's prior work with federal agencies like the NIH and USDA, where they have received funding for projects involving rapid hepatitis C diagnostics and swine Streptococcus suis vaccines.
Quick answers
Who was awarded contract W911QY20C0114?
W911QY20C0114 was awarded to Pathovacs Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on September 1, 2020.
How much is contract W911QY20C0114 worth?
The government has obligated $975,606 on W911QY20C0114.
Which agency awarded contract W911QY20C0114?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY20C0114, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W911QY20C0114 competed?
The extent of competition for W911QY20C0114 was full and open competition after exclusion of sources. The government received 11 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award